8-K 1 form8-k080205.htm 8-K 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 2, 2005


MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)



Delaware 1-11394 95-3863205
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation)   Identification No.)



402 West County Road D, St. Paul, Minnesota 55112
(Address of principal executive offices) (Zip Code)



Registrant’s telephone number, including area code: (651) 636-7466


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.    Other Events

On August 2, 2005, MEDTOX Scientific, Inc. announced the number of warrants that were converted to common stock, as described in the press release attached as Exhibit 99.1.

2


Item 9.01.    Financial Statements and Exhibits.


(c) Exhibits.

        The following exhibit is filed as part of this report:


Exhibit No. Description
10.1 MEDTOX Scientific, Inc. Press Release, dated August 2, 2005.

3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  MEDTOX Scientific, Inc.  
     
     
     
Date:   August 2, 2005 By:          /s/ Richard J. Braun  
  Name:     Richard J. Braun
  Title:       Chief Executive Officer

4



INDEX TO EXHIBITS


Exhibit No. Description
10.1 MEDTOX Scientific, Inc. Press Release, dated August 2, 2005.

5